Actinex is a medicine used to treat severe allergic reactions. It works by stopping the body's reaction to certain allergens, like those found in insect stings or bee venom. It helps prevent serious problems like swelling or difficulty breathing.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Masoprocol is a prescription skin cream that was sold in the United States as Actinex, a 10% cream, to treat actinic keratoses. Actinic keratoses are rough, scaly patches that form on skin with years of sun exposure, such as the face, lips and neck. They matter because a small share can progress to skin cancer, specifically a type called squamous cell carcinoma, which is why dermatologists usually treat them rather than simply watching them. The US Food and Drug Administration (FDA) approved Actinex in 1992, but it has since been discontinued in the US and there is no current US prescribing label. Masoprocol is therefore mostly of historical interest. People with actinic keratoses today are offered other options: prescription creams such as fluorouracil, imiquimod, diclofenac gel or tirbanibulin, which treat a whole area of sun-damaged skin; freezing individual spots with liquid nitrogen (cryosurgery); photodynamic therapy, which uses a light-activated medicine; or laser treatment.
Masoprocol is a purified form of a natural compound first found in the creosote bush, a desert shrub. It is an antioxidant, and in laboratory studies it blocks several enzymes, including 5-lipoxygenase, an enzyme the body uses to make inflammatory chemicals, as well as signals that help abnormal cells grow. Applied to the skin, it was intended to stop or reverse the overgrowth of sun-damaged skin cells that forms an actinic keratosis. Exactly which of these effects explains its benefit in people was never firmly established.
In the main clinical trial, people applied masoprocol cream to the affected skin twice a day for two to four weeks, then stopped and were checked a month later. Course lengths for creams that treat a whole area of sun-damaged skin vary widely by product. Because the product is no longer sold in the US, there is no current official guidance on how to use it. Anyone who comes across masoprocol cream, such as an old tube, should ask a clinician before applying it rather than following past instructions.
Skin irritation at the treated area was the main side effect. In the key trial, redness or flaking affected about six in ten people who used masoprocol, compared with about a quarter of those using an inactive cream. How irritated the skin became did not predict how well the treatment worked, so a strong reaction was not a sign of greater benefit. Masoprocol can also cause an allergic skin reaction. Allergic contact reactions have been reported, and it has been described as a potent sensitizer, meaning the immune system can become allergic to it after exposure. Itching, swelling or a rash that is worse than expected, or that spreads beyond the treated skin, is a reason to stop and contact a clinician.
With no current US label, there is no up-to-date official list of interactions, contraindications or pregnancy guidance for masoprocol. That gap is a practical reason to prefer the actively marketed treatments for actinic keratoses, whose risks and directions are documented. A form of masoprocol taken by mouth has been studied in cancer research, but it was never approved and is not the same as the skin cream. Because some actinic keratoses turn into squamous cell carcinoma, a spot that bleeds, becomes tender, forms a hard horn-like growth, or does not clear after treatment should be examined by a dermatologist soon.
In the main trial of 113 people treated on the head and neck, the average number of actinic keratoses fell from about 15 to about 5 one month after treatment, a typical reduction of roughly 70%. People using the inactive cream saw little change (a typical reduction of about 4%). That is a clear short-term effect, but it comes from a single study from the early 1990s, with no long-term follow-up and no direct comparison with treatments in use today. Masoprocol was never shown to lower the chance of later skin cancer. For comparison, one large trial of fluorouracil cream in people who had already had skin cancers found fewer squamous cell carcinomas in the year after treatment, though the difference did not last over the following years. People with actinic keratoses usually have widespread sun damage, so new spots tend to keep appearing. Regular skin checks with a dermatologist and daily sun protection remain part of care whichever treatment is used.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Masoprocol, what you've noticed, or ask the community a question.